chr16-1911862-C-T
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_001009606.4(HS3ST6):c.757G>A(p.Val253Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000634 in 1,608,772 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001009606.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
HS3ST6 | NM_001009606.4 | c.757G>A | p.Val253Ile | missense_variant | Exon 2 of 2 | ENST00000454677.3 | NP_001009606.3 | |
HS3ST6 | XM_011522608.3 | c.382G>A | p.Val128Ile | missense_variant | Exon 2 of 2 | XP_011520910.1 | ||
HS3ST6 | XM_011522609.2 | c.337G>A | p.Val113Ile | missense_variant | Exon 2 of 2 | XP_011520911.1 | ||
HS3ST6 | XM_047434487.1 | c.337G>A | p.Val113Ile | missense_variant | Exon 2 of 2 | XP_047290443.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000460 AC: 7AN: 152232Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000110 AC: 27AN: 244810Hom.: 0 AF XY: 0.0000979 AC XY: 13AN XY: 132848
GnomAD4 exome AF: 0.0000652 AC: 95AN: 1456422Hom.: 0 Cov.: 40 AF XY: 0.0000525 AC XY: 38AN XY: 724216
GnomAD4 genome AF: 0.0000459 AC: 7AN: 152350Hom.: 0 Cov.: 33 AF XY: 0.0000268 AC XY: 2AN XY: 74490
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.664G>A (p.V222I) alteration is located in exon 2 (coding exon 2) of the HS3ST6 gene. This alteration results from a G to A substitution at nucleotide position 664, causing the valine (V) at amino acid position 222 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at